The HER-2/neu story: From oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy

Research output: Contribution to a Journal (Peer & Non Peer) › Editorial

4 Citations (Scopus)

Original language	English
Pages (from-to)	111-112
Number of pages	2
Journal	European Journal of Surgical Oncology
Volume	25
Issue number	2
DOIs	https://doi.org/10.1053/ejso.1998.0611
Publication status	Published - 1999
Externally published	Yes

Access to Document

@article{b1115298af1148f288637ffd2e5158c6,

title = "The HER-2/neu story: From oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy",

author = "Mehigan, \{B. J.\} and Kerin, \{M. J.\}",

year = "1999",

doi = "10.1053/ejso.1998.0611",

language = "English",

volume = "25",

pages = "111--112",

journal = "European Journal of Surgical Oncology",

issn = "0748-7983",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - The HER-2/neu story

T2 - From oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy

AU - Mehigan, B. J.

AU - Kerin, M. J.

PY - 1999

Y1 - 1999

UR - https://www.scopus.com/pages/publications/0032913299

U2 - 10.1053/ejso.1998.0611

DO - 10.1053/ejso.1998.0611

M3 - Editorial

C2 - 10218450

AN - SCOPUS:0032913299

SN - 0748-7983

VL - 25

SP - 111

EP - 112

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

IS - 2

ER -